These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2819882)

  • 21. Brain opioid receptor binding of [3H]CTOP and [3H]naltrindole in alcohol-preferring AA and alcohol-avoiding ANA rats.
    Soini SL; Ovaska T; Honkanen A; Hyytiä P; Korpi ER
    Alcohol; 1998 Apr; 15(3):227-32. PubMed ID: 9539380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences.
    Wood PL
    Peptides; 1983; 4(5):595-601. PubMed ID: 6318197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for the presynaptic localization of opiate binding sites on striatal efferent fibers.
    Abou-Khalil B; Young AB; Penney JB
    Brain Res; 1984 Dec; 323(1):21-9. PubMed ID: 6098334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-D-penicillamine, 5-D-penicillamine]enkephalin (125I-DPDPE).
    Dilts RP; Kalivas PW
    Synapse; 1990; 6(2):121-32. PubMed ID: 1978419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal opiate mu-receptors are not located on dopamine nerve endings in the rat.
    Trovero F; Herve D; Desban M; Glowinski J; Tassin JP
    Neuroscience; 1990; 39(2):313-21. PubMed ID: 1982345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked increase in histamine H3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons: an autoradiographic study.
    Ryu JH; Yanai K; Watanabe T
    Neurosci Lett; 1994 Aug; 178(1):19-22. PubMed ID: 7816330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system: an in situ hybridization study.
    Georges F; Normand E; Bloch B; Le Moine C
    Brain Res Dev Brain Res; 1998 Aug; 109(2):187-99. PubMed ID: 9729374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists.
    Matsumoto RR; Brinsfield KH; Patrick RL; Walker JM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):196-203. PubMed ID: 2839661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies.
    Pollard H; Llorens C; Schwartz JC; Gros C; Dray F
    Brain Res; 1978 Aug; 151(2):392-8. PubMed ID: 209865
    [No Abstract]   [Full Text] [Related]  

  • 30. Localization of striatal opioid gene expression, and its modulation by the mesostriatal dopamine pathway: an in situ hybridization study.
    Morris BJ; Herz A; Höllt V
    J Mol Neurosci; 1989; 1(1):9-18. PubMed ID: 2561993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative development of striatal opiate receptors and dopamine revealed by autoradiography and histofluorescence.
    Moon Edley S; Herkenham M
    Brain Res; 1984 Jul; 305(1):27-42. PubMed ID: 6331599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific mu 2 opioid isoreceptor regulation of nigrostriatal neurons: in vivo evidence with naloxonazine.
    Wood PL; Pasternak GW
    Neurosci Lett; 1983 Jun; 37(3):291-3. PubMed ID: 6310456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exofocal alterations in opioidergic receptor densities following focal cerebral ischemia in the mouse.
    Boutin H; Dauphin F; Jauzac P; MacKenzie ET
    Exp Neurol; 2000 Aug; 164(2):314-21. PubMed ID: 10915570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
    Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
    J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats.
    Jiang HK; Wang JY
    Chin J Physiol; 1991; 34(4):413-25. PubMed ID: 1687937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes.
    Stiene-Martin A; Zhou R; Hauser KF
    Glia; 1998 Mar; 22(3):249-59. PubMed ID: 9482211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system.
    Dilts RP; Kalivas PW
    Brain Res; 1989 May; 488(1-2):311-27. PubMed ID: 2545303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autoradiographic distribution of [3H]ohmefentanyl binding sites in rat corpus striatum].
    Yao YH; Xu H; Li GF; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1988 May; 9(3):212-5. PubMed ID: 2850709
    [No Abstract]   [Full Text] [Related]  

  • 40. Increases in [3H]FK-506 and [3H]L-N(G)-nitro-arginine binding in the rat brain after nigrostriatal dopaminergic denervation.
    Araki T; Tanji H; Fujihara K; Kato H; Itoyama Y
    Metab Brain Dis; 1999 Mar; 14(1):21-31. PubMed ID: 10348311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.